The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions
Biology · 28.02.2025 · 14 (3) · 251
DOI: 10.3390/biology14030251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 28.02.2025. Verfasst von Imen Zalila-Kolsi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical and Health Sciences, Liwa College, Abu Dhabi P.O. Box 41009, United Arab Emirates. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
CRC remains a significant public health challenge due to its high prevalence and mortality rates. Emerging evidence highlights the critical role of the gut microbiota in both the pathogenesis of CRC and the efficacy of treatment strategies, including chemotherapy and immunotherapy. Dysbiosis, characterized by imbalances in microbial communities, has been implicated in CRC progression and therapeutic outcomes. This review examines the intricate relationship between gut microbiota composition and CRC, emphasizing the potential for microbial profiles to serve as biomarkers for early detection and prognosis. Various interventions, such as prebiotics, probiotics, postbiotics, fecal microbiota transplantation, and dietary modifications, aim to restore microbiota balance and shift dysbiosis toward eubiosis, thereby improving health outcomes. Additionally, the integration of microbial profiling into clinical practice could enhance diagnostic capabilities and personalize treatment strategies, advancing the field of oncology. The study of intratumoral microbiota offers new diagnostic and prognostic tools that, combined with artificial intelligence algorithms, could predict treatment responses and assess the risk of adverse effects. Given the growing understanding of the gut microbiome–cancer axis, developing microbiota-oriented strategies for CRC prevention and treatment holds promise for improving patient care and clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medical and Health Sciences, Liwa College, Abu Dhabi P.O. Box 41009, United Arab Emirates.
- College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
ORCID-Profile: Dhoha Dhieb, Hussam A Osman
Zitieren
APA
Zalila-Kolsi, I., Dhieb, D., Osman, H. A., & Mekideche, H. (2025). The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions. Biology, 14(3), 251. https://doi.org/10.3390/biology14030251
Vancouver
Zalila-Kolsi I, Dhieb D, Osman HA, Mekideche H. The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions. Biology. 2025;14(3):251. doi:10.3390/biology14030251
BibTeX
@article{ZalilaKolsi2025,
author = {Zalila-Kolsi, Imen and Dhieb, Dhoha and Osman, Hussam A and Mekideche, Hadjer},
title = {The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions},
journal = {Biology},
year = {2025},
volume = {14},
number = {3},
pages = {251},
doi = {10.3390/biology14030251}
}
EUVIMED